Coya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (COYA) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2022 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
COYA on Nasdaq
Shares outstanding
16,681,212
Price per share
$5.80
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
4,755,804
Total reported value
$27,110,326
% of total 13F portfolios
0%
Share change
+271,118
Value change
+$1,543,439
Number of holders
35
Price from insider filings
$5.80
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Coya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (COYA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
DME Capital Management, LP 9.9% $10,783,903 1,651,440 DME Advisors GP, L.L.C. 31 Dec 2024
HIRSCHMAN ORIN 8% $8,710,491 1,333,919 Orin Hirschman 31 Dec 2024

As of 30 Sep 2025, 35 institutional investors reported holding 4,755,804 shares of Coya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (COYA). This represents 29% of the company’s total 16,681,212 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Coya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (COYA) together control 28% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
DME Capital Management, LP 9.9% 1,646,440 0% 0.37% $9,384,708
AIGH Capital Management LLC 6.6% 1,105,622 0% 2.2% $6,302,046
VANGUARD GROUP INC 5% 836,393 -0.49% 0% $4,767,440
CM Management, LLC 1.8% 300,000 +50% 1.4% $1,710,000
GEODE CAPITAL MANAGEMENT, LLC 0.94% 156,845 -0.15% 0% $894,277
Dauntless Investment Group, LLC 0.92% 153,021 +200% 2.3% $872,220
BlackRock, Inc. 0.42% 69,958 +2.5% 0% $398,761
CITADEL ADVISORS LLC 0.39% 65,240 +51% 0% $371,868
STATE STREET CORP 0.29% 48,100 0% 0% $274,170
MARSHALL WACE, LLP 0.25% 41,825 0% $238,404
PRELUDE CAPITAL MANAGEMENT, LLC 0.21% 35,770 0% 0.02% $203,889
ROYAL BANK OF CANADA 0.21% 35,383 +164% 0% $202,000
RENAISSANCE TECHNOLOGIES LLC 0.21% 34,800 +149% 0% $198,360
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.2% 33,355 -33% 0% $190,124
NORTHERN TRUST CORP 0.19% 32,321 -18% 0% $184,230
GHP Investment Advisors, Inc. 0.16% 26,171 0% 0.01% $149,175
Prosperity Wealth Management, Inc. 0.14% 23,800 +16% 0.05% $135,660
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 0.12% 20,626 0% 0% $117,568
Quadrature Capital Ltd 0.12% 19,894 0% $113,794
DIMENSIONAL FUND ADVISORS LP 0.12% 19,781 0% 0% $112,752
UBS Group AG 0.08% 13,298 -12% 0% $75,799
Lantern Wealth Advisors, LLC 0.07% 11,575 0.04% $65,978
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.06% 10,000 0% 0% $57,000
JPMORGAN CHASE & CO 0.03% 5,000 0% $28,500
State of Wyoming 0.02% 3,260 -6.1% 0% $18,582

Institutional Holders of Coya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (COYA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 2,695 $15,631 +$15,631 $5.80 1
2025 Q3 4,755,804 $27,110,326 +$1,543,439 $5.70 35
2025 Q2 4,484,686 $25,787,239 -$1,022,977 $5.75 33
2025 Q1 4,662,591 $30,167,676 +$1,480,613 $6.47 26
2024 Q4 4,444,580 $25,467,940 +$6,454,839 $5.73 26
2024 Q3 3,315,161 $21,385,210 +$304,078 $6.45 19
2024 Q2 3,268,292 $19,805,900 -$932,467 $6.06 19
2024 Q1 3,339,060 $33,123,748 +$5,311,359 $9.92 19
2023 Q4 2,822,037 $20,644,859 +$10,288,077 $7.41 20
2023 Q3 1,416,355 $5,449,280 +$229,488 $3.84 14
2023 Q2 1,351,642 $5,500,530 +$1,016,457 $4.07 13
2023 Q1 1,101,849 $4,368,596 +$41,079 $3.97 7
2022 Q4 1,091,417 $5,156,354 +$5,156,354 $4.74 4